Pharmaceuticals

Novel Spectrometry Platforms Market Size, Share & Trends Analysis Report By Type of Spectrometers (Atomic Absorption Spectrometer, Mass Spectrometer, Near Infrared Spectrometer, Nuclear Magnetic Resonance Spectrometer, Raman Spectrometer, and X-Ray Fluorescence Spectrometer), By End-user, By Region, And By Segment Forecasts, 2023-2031

The Novel Spectrometry Platforms Market Size is valued at USD 13.47 Billion in 2023 and is predicted to reach USD 24.92 Billion by the year 2031 at an 8.4 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The increasing complex nature of drug molecules and the need for detailed analysis boost the demand for advanced spectrometry platforms. Rising environmental concerns and regulatory ...

Report ID: 1356  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

Lab Workflow Optimization Market Size, Share & Trends Analysis Report, By Type of Solution (Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELN), Laboratory Automation Systems, Scientific Data Management Systems (SDMS), Laboratory Execution Systems (LES), Inventory Management Systems, and Others), By End User (Pharmaceutical and Biotechnology Organizations, Academic and Research Institutes, Contract Research Organizations (CROs), Clinical Diagnostics Laboratories, Food and Beverage Laboratories, Environmental Testing Laboratories, and Others), By Region, Forecasts, 2024-2031

Lab Workflow Optimization Market Size is predicted to develop a 7.1% CAGR during the forecast period for 2024-2031. The primary drivers behind market expansion include the increasing prevalence of laboratory tests and the growing trend of outsourcing laboratory services. As the global population ages and expands, there's a heightened demand for healthcare services, particularly diagnostic testing. Consequently, there's a surge in laboratory te...

Report ID: 2496  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

3D Printing Photopolymer Market Size, Share & Trends Analysis Report, By Material (Polymers, Oligomers, Monomers, Additives, and Other), By Application (Surgical Models, Wearable Biosensors, Customized Prosthetics, Exoskeletons, and Hearing Aids), By Region, Forecasts, 2024-2031

3D Printing Photopolymer Market Size was valued at USD 929.5 Mn in 2023 and is predicted to reach USD 2,902.4 Mn by 2031 at a 15.5% CAGR during the forecast period for 2024-2031. The global 3D printing photopolymer market is expected to grow during the forecast period. The process of 3D printing material is also known as additive manufacturing, which is the production process of quick and easy 3D printed devices. The use of 3D printing allows ...

Report ID: 2486  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

Erectile Dysfunction Drugs Market by Drug (Avanafil (Stendra), Muse Suppository (Alprostadil), Sildenafil (Viagra)), Mode of Administration (Injections, Oral, Topical), Distribution Channel, Region And Segment Forecasts, 2024-2031

Erectile Dysfunction Drugs Market Size is valued at USD 2.58 billion in 2023 and is predicted to reach USD 4.60 billion by the year 2031 at a 7.7% CAGR during the forecast period for 2024-2031. Erectile dysfunction refers to the condition where an individual is unable to gain or maintain an erection for a sufficient duration to engage in sexual activity. Sedentary lifestyle-related chronic disorders, including obesity, heart disease, diabetes,...

Report ID: 2483  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

Topical Drug Delivery Market Size, Share & Trends Analysis Report By Type (Semi-solids (Creams, Gels, Lotions), Solids (Suppositories), Liquids (Solutions), Transdermal Products), Route (Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres), Region And Segment Forecasts, 2023-2031

Topical Drug Delivery Market Size is valued at USD 208.25 billion in 2022 and is predicted to reach USD 418.70 billion by the year 2031 at a 8.1% CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: The main reasons driving this market's growth are the rising rates of minor illnesses like acne and psoriasis as well as skin diseases like eczema. Transdermal delivery of biologics i...

Report ID: 2081  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

Serotonin Supplement Market Size, Share & Trends Analysis Report, By Type (Standard Grade Celecoxib API, & Micronized Celecoxib API), By Application (Pharmaceutical, & Laboratory), By Region, Forecasts, 2024-2031

Serotonin Supplement Market Size was valued at USD 939.6 Mn in 2023 and is predicted to reach USD 1,355.5 Mn by 2031 at a 4.8% CAGR during the forecast period for 2024-2031. Serotonin supplement is a neurotransmitter that helps control appetite, sleep, and mood; increasing blood levels of the neurotransmitter is the major objective of serotonin supplements. Mood, sleep, and mental health issues are common reasons people take these supplements....

Report ID: 2477  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

Gemigliptin Market Size, Share & Trends Analysis Report By Type of Drug (Gemigliptin Monotherapy & Gemigliptin Combination Therapy), By Dosage Form (Gemigliptin Tablets & Gemigliptin Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, & Online Pharmacies), By End-User, By Application, By Patient Demographics, Region And Segment Forecasts, 2023-2031

The Gemigliptin Market Size is valued at USD 1.66 billion in 2022 and is predicted to reach USD 2.65 billion by the year 2031 at a 5.5% CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: Gemigliptin effectiveness in glycemic control, often in combination with other antidiabetic agents, has contributed to its widespread adoption. Greater awareness among patients about the importance of glycemi...

Report ID: 2031  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Size, Share & Trends Analysis Report By Drug Class (Bronchodilators, Combination, Corticosteroids, Phosphodiesterase), By Type (Chronic Bronchitis, Emphysema), By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Size is valued at USD 19.49 Bn in 2023 and is predicted to reach USD 33.61 Bn by the year 2031 at a 7.20% CAGR during the forecast period for 2024-2031.  Key Industry Insights & Findings from the Report: The increasing government initiatives and investments for research and developments drive the market growth. Rising clinical trials as well as awareness for the COP...

Report ID: 2311  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 179

Pharmaceutical Fine Chemicals Market (By Product (Basic Building Blocks, Advanced intermediates, and Active ingredients), Type (Proprietary, Non-proprietary), Chemical (Small Molecules, Big Molecules), By Application (Cardiovascular, Neurology, Oncology, Infectious diseases, Metabolic system, Diabetes, Respiratory diseases, Gastrointestinal diseases, Musculoskeletal diseases, and Other), By Region, And By Segment Forecasts, 2024-2031

Pharmaceutical Fine Chemicals Market Size is valued at USD 133.8 Bn in 2023 and is predicted to reach USD 246.5 Bn by the year 2031 at a 8.15% CAGR during the forecast period for 2024-2031. Pharmaceutical fine chemicals describe the class of chemicals that are employed in the pharmaceutical industry. In contrast to the processed compounds found in most pharmaceuticals, they are pure substances. The number of people with various chronic health...

Report ID: 2462  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

Biomarker Discovery Outsourcing Services Market Size, Share and Growth Analysis 2026 to 2035

Biomarker Discovery Outsourcing Services Market Size is valued at USD 17.05 billion in 2025 and is predicted to reach USD 108.03 billion by the year 2035 at a 20.4% CAGR during the forecast period for 2026 to 2035.  Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints), Therapeutic Area (Oncology, Neurology, C...

Report ID: 2191  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 179